Tag: risperdal

Whistleblower Award

Whistleblower Lawsuit Against Omnicare Nets $124 Million for Federal Government

The Federal government has accepted a $124 million settlement from Omnicare to resolve several claims initiated by company employees who reported illegal kickbacks and other improprieties to regulators.  Omnicare is the largest provider of pharmaceuticals and[...]

Risperdal Lawsuit Bars Claims for Punitive Damages

Risperdal Lawsuits Time Barred, Argues Johnson & Johnson

Janssen Pharmaceuticals, a division of Johnson & Johnson  that manufactured and marketed the antipsychotic drug Risperdal to adolescent males, asked a Pennsylvania court in a Motion for Summary Judgment dated May 19, 2014, to hold that[...]

Whistleblower Award

Whistleblower Lawsuits On The Rise

Whistleblower claims, or "qui tam" lawsuits, brought under the federal False Claims Act, increased to 753 in 2013, an increase of almost 20% over the previous year.*  These claims resulted in aggregate net recoveries to the[...]